%0 Journal Article
%T Disease burden of spinal muscular atrophy in Germany
%A Constanze Klug
%A Elisabeth Schorling
%A Janet Zowe
%A Klaus H. Nagels
%A Maggie C. Walter
%A Olivia Schreiber-Katz
%A Peter Reilich
%A Simone Thiele
%J Archive of "Orphanet Journal of Rare Diseases".
%D 2016
%R 10.1186/s13023-016-0424-0
%X This study aimed at analyzing the economic burden and disease-specific health-related quality of life (HRQOL) of patients with spinal muscular atrophy (SMA) in Germany. SMA is a so far non-curable neuromuscular disease of the anterior nerve cells that causes high rates of morbidity and mortality
%K Spinal muscular atrophy (SMA)
%K Health-related quality of life (HRQOL)
%K Direct cost
%K Indirect cost
%K Informal care cost
%K Cost of illness (COI)
%K Health care burden
%K Neuromuscular disease
%K Health services research
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857429/